We are live on ! Find out more
AST.WS

Asterias Biotherapeutics Warrants

Delisted

AST.WS was delisted on the 26th of September, 2017.

35 hedge funds and large institutions have $362K invested in Asterias Biotherapeutics Warrants in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,959% more capital inflows, than outflows

Capital inflows: $41.2K | Capital outflows: $2K

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

3% less funds holding

Funds holding: 36 → 35 (-1)

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

AST.WS Hedge Fund Activity: Q1 2017 in Review

35 of the 4,036 institutional investors tracked by Wall St. Rank reported a position in Asterias Biotherapeutics Warrants (AST.WS) for Q1 2017, worth a combined $362K — down 11% from $406K a quarter earlier.

Fund positioning in AST.WS was balanced in Q1 2017: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 2 trimmed.

The largest buyer was CSS LLC, opening a new position worth an estimated $39.9K. The largest seller was California State Teachers Retirement System (CalSTRS), exiting entirely with an estimated $2K sold.

  • 35 institutional investors held Asterias Biotherapeutics Warrants (AST.WS) as of Q1 2017, down from 36 in Q4 2016.
  • Funds reported $362K of Asterias Biotherapeutics Warrants stock for Q1 2017, down 11% quarter-over-quarter.
  • 3 funds opened new Asterias Biotherapeutics Warrants positions in Q1 2017 and 3 closed out, a net change of 0 holders.
  • The largest Asterias Biotherapeutics Warrants buyer in Q1 2017 was CSS LLC, an estimated $39.9K added.
  • The largest Asterias Biotherapeutics Warrants seller in Q1 2017 was California State Teachers Retirement System (CalSTRS), an estimated $2K sold.

Based on aggregated 13F filings for Q1 2017.